HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
We were thrilled to have been a Gold sponsor at the SFB conference this year.
Our business manager, Patrick McDaniel, our Chief Scientific Officer, Anthony Bresin, our Innovation Project Manager, Mélanie Leroux, and our partner Echelon Biosciences were all in attendance, seeking opportunities to connect with other professionals in the field of Tissue Engineering & Regenerative Medicine.
We’re pleased to share our second CSR report, highlighting the actions and commitments we carried out throughout 2024.
A Global Scientific Gathering Dedicated to Hyaluronic Acid Innovation.
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.